Uncategorized

STAT+: Biotech company co-founded by top autoimmune researcher lays out plans with antibody therapies

Over the last five years, German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment, showing that CAR-T therapy could be used to reset patients’ immune systems. 

He has become a scientific adviser de rigueur for the field, joining a half-dozen startup advisory boards. 

Now, for the first time, he’s co-founding a biotech company. But it has no immediate plans to work in CAR-T. 

Continue to STAT+ to read the full story…

​Read More

Published

on

Over the last five years, German researcher Georg Schett has made a name for himself as a pioneer in autoimmune disease treatment, showing that CAR-T therapy could be used to reset patients’ immune systems. 

He has become a scientific adviser de rigueur for the field, joining a half-dozen startup advisory boards. 

Now, for the first time, he’s co-founding a biotech company. But it has no immediate plans to work in CAR-T. 

Continue to STAT+ to read the full story…

​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version